Keeping the Psychedelic Renaissance from Running Off the Rails

Friday, September 8, 2023

5:15 PM – 6:30 PM CT

Location: Davidson C

Speaker(s)

Charles Raison, MD

Professor
University of Wisconsin-Madison
University of Wisconsin-Madison
Andrew Penn, MS, PMHNP

Clinical Professor
University of California, San Francisco, School of Nursing
University of California, San Francisco

The introduction of psychedelic assisted therapies (PAT) marks one of the most significant changes in available treatments for our patients. While much research has been conducted to get the treatments through the FDA, there is much that is still not known and will need to be considered when determining how to use these treatments. Complicating matters are the cultural and policy issues around psychedelics such as decriminalization and recreational use that may already be impacting our patients. This session, led by two expert researchers in the field, will attempt to disentangle these issues and prepare clinicians to thoughtfully deploy these treatments.

Developed in partnership with SANA

Developed in collaboration with Sana Symposium, the official meeting of the Psychedelic Medicine Association, these sessions were designed to deliver promising research and breakthrough treatment therapies from the emerging field of psychedelic therapies.

Learning Objectives:

List 6 stakeholders in the psychedelic space and their key interests
Describe key knowledge gaps in the use of psychedelic assisted therapy (PAT)
Identify patients that current studies indicate would be most likely to benefit from PAT